Cargando…
A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis
BACKGROUND: The prognosis of patients with recurrences from stage 4 neuroblastoma is not uniformly dismal. The evaluation of new therapies therefore needs to consider the individual risks of the treated patients. This study aims to define clinically useful risk criteria. PATIENTS AND METHODS: Inclus...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885891/ https://www.ncbi.nlm.nih.gov/pubmed/31631570 http://dx.doi.org/10.1002/cam4.2562 |